Nicolas Goardon

Caen, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Technical recommendations from a large-scale French Delphi consensus: A step toward European harmonization of ctDNA analysis.

Technical recommendations from a large-scale French Delphi consensus: A step toward European harmonization of ctDNA analysis.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 19, 2026

GFCO national recommendations on the use of liquid biopsy for circulating tumor DNA analysis in oncology

GFCO national recommendations on the use of liquid biopsy for circulating tumor DNA analysis in oncology

Journal: Bulletin du cancer

Published: December 10, 2025

Decipher RNA isoform combinations from minigene splicing assays and massive parallel sequencing with MAGIC.

Decipher RNA isoform combinations from minigene splicing assays and massive parallel sequencing with MAGIC.

Journal: Bioinformatics (Oxford, England)

Published: June 05, 2025

Fine mapping of RNA isoform diversity using an innovative targeted long-read RNA sequencing protocol with novel dedicated bioinformatics pipeline.

Fine mapping of RNA isoform diversity using an innovative targeted long-read RNA sequencing protocol with novel dedicated bioinformatics pipeline.

Journal: BMC genomics

Published: April 30, 2024

Carboplatin in metastatic castration-resistant prostate cancer patients with molecular alterations of the DNA damage repair pathway: the PRO-CARBO phase II trial.

Carboplatin in metastatic castration-resistant prostate cancer patients with molecular alterations of the DNA damage repair pathway: the PRO-CARBO phase II trial.

Journal: Therapeutic advances in urology

Published: June 27, 2023

Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer.

Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 27, 2023

ORGAVADS: establishment of tumor organoids from head and neck squamous cell carcinoma to assess their response to innovative therapies.

ORGAVADS: establishment of tumor organoids from head and neck squamous cell carcinoma to assess their response to innovative therapies.

Journal: BMC cancer

Published: January 11, 2023

TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma.

TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma.

Journal: BMC cancer

Published: December 23, 2021

Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial.

Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial.

Journal: Journal of the National Cancer Institute

Published: June 05, 2020

Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study.

Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study.

Journal: Endocrine

Published: May 06, 2020

Assessment of branch point prediction tools to predict physiological branch points and their alteration by variants.

Assessment of branch point prediction tools to predict physiological branch points and their alteration by variants.

Journal: BMC genomics

Published: July 16, 2019

Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol.

Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol.

Journal: BMC cancer

Published: November 26, 2018

Showing 1-12 of 20

Last Updated: 09/26/2026